INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,566 Cr | ₹1,581 Cr | ₹1,383 Cr | ₹1,215 Cr | ₹1,023 Cr |
What is the latest Total Expenditure of INDOCO REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹1,566 Cr |
| Mar2024 | ₹1,581 Cr |
| Mar2023 | ₹1,383 Cr |
| Mar2022 | ₹1,215 Cr |
| Mar2021 | ₹1,023 Cr |
How is Total Expenditure of INDOCO REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,566 Cr | -0.96 | |
| Mar2024 | ₹1,581 Cr | 14.34 | |
| Mar2023 | ₹1,383 Cr | 13.84 | |
| Mar2022 | ₹1,215 Cr | 18.70 | |
| Mar2021 | ₹1,023 Cr | - | |
Compare Total Expenditure of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,870.5 Cr | 0.9% | -6.4% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 0.9% |
-6.4% |
-14.4% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses